The role of vitamin D for the management of depression in patients with autoimmune thyroiditis and hypothyroidism in the West-Ukrainian population
Keywords:autoimmune thyroiditis, hypothyroidism, depression
Background. Hashimoto’s thyroiditis is known to be an essential endocrine disease that affects the population and may lead to hypothyroidism. This disease is one of the most commonly spread autoimmune diseases. Hypothyroid patients frequently experience features of depression, which is prevalent among other symptoms in hypothyroidism. Data from recent research has proved that vitamin D deficiency may cause depression manifestations in the population. The purpose of the work is to study the effect of cholecalciferol in patients with autoimmune thyroiditis and hypothyroidism in the West-Ukrainian population on the level of depression in these patients. Materials and methods. The study included the 56 patients with hypothyroidism (H) caused by autoimmune thyroiditis (AIT). We identified the severity of depression levels using the Hamilton Depression Rating Scale (HDRS), which is reliable for depression assessment. Examinations were performed at the beginning and end of the 12-week treatment. Results. In patients of group 1 who received cholecalciferol and L-thyroxine, the level of depression on the Hamilton scale decreased by 40 %, while in patients who received only L-thyroxine, the level of depression decreased by 25 %. In addition, there was a significant difference between patients in groups 1 and 2 after treatment (p = 0.003). That is, treatment with additional cholecalciferol on the background of L-thyroxine was more effective than treatment with L-thyroxine alone. Analyzing the effect of treatment in patients with Group 1 with the additional appointment of cholecalciferol on the background of L-thyroxine in 21.4 % of patients disappeared depression. In addition, there was a decrease in depression in other patients in this group. Thus, in the remaining patients the severity of depressive manifestations decreased from moderate severity to mild depressive disorder. At the same time, after treatment only L-thyroxine depressive disorder of moderate severity decreased from 78.6 to 35.7 % to mild depressive disorder, but complete disappearance of depression in this group of patients after treatment was not observed. Conclusions. Vitamin D supplementation should be administered in patients suffering from autoimmune thyroiditis and hypothyroidism which may correct depression disorders in these patients.
Gorkhali B, Sharma S, Amatya M, Acharya D, Sharma M. Anxiety and Depression among Patients with Thyroid Function Disorders. J Nepal Health Res Counc. 2020;18(3):373-378. doi: 10.33314/jnhrc.v18i3.2499.
Ittermann T, Völzke H, Baumeister SE, Appel K, Grabe HJ. Diagnosed thyroid disorders are associated with depression and anxiety. Soc Psychiatry Psychiatr Epidemiol. 2015;50(9):1417-25. doi: 10.1007/s00127-015-1043-0.
Krysiak R, Kowalcze K, Okopień B. The impact of exogenous vitamin D on thyroid autoimmunity in euthyroid men with autoimmune thyroiditis and early-onset androgenic alopecia. Pharmacol Rep. 2021 Oct;73(5):1439-1447. doi: 10.1007/s43440-021-00295-3.
Garber JR, Cobin RH, Gharib H, et al; American Association of Clinical Endocrinologists and American Thyroid Association Taskforce on Hypothyroidism in Adults. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012 Nov-Dec;18(6):988-1028. doi: 10.4158/EP12280.GL.
Siegmann EM, Müller HHO, Luecke C, Philipsen A, Kornhuber J, Grömer TW. Association of Depression and Anxiety Disorders With Autoimmune Thyroiditis: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2018 Jun 1;75(6):577-584. doi: 10.1001/jamapsychiatry.2018.0190.
Wang S, Liu Y, Zhao N, et al. IL-34 Expression Is Reduced in Hashimoto's Thyroiditis and Associated With Thyrocyte Apoptosis. Front Endocrinol (Lausanne). 2018 Oct 23;9:629. doi: 10.3389/fendo.2018.00629.
Cai YJ, Wang F, Chen ZX, et al. Hashimoto's thyroiditis induces neuroinflammation and emotional alterations in euthyroid mice. J Neuroinflammation. 2018 Oct 29;15(1):299. doi: 10.1186/s12974-018-1341-z.
Roehlen N, Doering C, Hansmann ML, et al. Vitamin D, FOXO3a, and Sirtuin1 in Hashimoto's Thyroiditis and Differentiated Thyroid Cancer. Front Endocrinol (Lausanne). 2018 Sep 11;9:527. doi: 10.3389/fendo.2018.00527.
Moradi H, Sohrabi M, Taheri H, Khodashenas E, Movahedi A. The effects of different combinations of perceptual-motor exercises, music, and vitamin D supplementation on the nerve growth factor in children with high-functioning autism. Complement Ther Clin Pract. 2018 May;31:139-145. doi: 10.1016/j.ctcp.2018.02.005.
Sepehrmanesh Z, Kolahdooz F, Abedi F, et al. Vitamin D Supplementation Affects the Beck Depression Inventory, Insulin Resistance, and Biomarkers of Oxidative Stress in Patients with Major Depressive Disorder: A Randomized, Controlled Clinical Trial. J Nutr. 2016 Feb;146(2):243-8. doi: 10.3945/jn.115.218883.
Lopez RB, Denny BT, Fagundes CP. Neural mechanisms of emotion regulation and their role in endocrine and immune functioning: A review with implications for treatment of affective disorders. Neurosci Biobehav Rev. 2018 Dec;95:508-514. doi: 10.1016/j.neubiorev.2018.10.019.
Kaminskyi OV, Pankiv VI, Pankiv IV, Afanasyev DE. vitamin d content in population of radiologically contaminated areas in chernivtsi oblast (pilot project). Probl Radiac Med Radiobiol. 2018 Dec;23:442-451. English, Ukrainian. doi: 10.33145/2304-8336-2018-23-442-451.
Sabir MS, Haussler MR, Mallick S, et al. Optimal vitamin D spurs serotonin: 1,25-dihydroxyvitamin D represses serotonin reuptake transport (SERT) and degradation (MAO-A) gene expression in cultured rat serotonergic neuronal cell lines. Genes Nutr. 2018;13:19. doi: 10.1186/s12263-018-0605-7.
Moore ME, Piazza A, McCartney Y, Lynch MA. Evidence that vitamin D3 reverses age-related inflammatory changes in the rat hippocampus. Biochem Soc Trans. 2005 Aug;33(Pt 4):573-7. doi: 10.1042/BST0330573.
How to Cite
This work is licensed under a Creative Commons Attribution 4.0 International License.